A survey of bancroftian filariasis for microfilariae & circulating antigenaemia in two villages of Madhya Pradesh.

BACKGROUND & OBJECTIVE The estimation of filariasis prevalence in Panna district of Madhya Pradesh was so far relied upon clinical and night blood smear examination. However, night blood smear examination fails to detect the infection in individuals having low parasitaemia and cryptic filarial infection. The present study was undertaken to re-evaluate the prevalence of filariasis in two villages of Panna district by Og4C3 ELISA. METHODS The study was carried out during 2002-2003 in two villages (namely Pista and Taroni) of Panna district, Madhya Pradesh. Clinical examination was performed according to WHO criteria to classify filarial disease. Night blood smears collected during 20:00 to 00:00 h were examined to detect microfilariae (Mf). For estimation of circulating filarial antigen (CFA) by Og4C3 ELISA, 2 ml blood was collected from each individual by venepuncture. RESULTS With Og4C3 ELISA, 38 per cent serum samples of village Pista (n=332) and 47.7 per cent from village Taroni (n=88) were found positive for CFA. The overall disease rate was (243/ 420) 57.9 per cent by CFA while it was (182/420) 43.3 per cent by night blood smear examination. A total of 14.5 per cent individuals were having cryptic filarial infection detected by CFA. INTERPRETATION & CONCLUSION The study emphasizes the use of CFA estimation being a sensitive and specific diagnostic tool for the evaluation of the true prevalence of the disease. The high CFA prevalence in the study area necessitates early intervention measures to check its transmission.

[1]  P. Vanamail,et al.  Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India. , 2004, The Journal of communicable diseases.

[2]  D. Meyrowitsch,et al.  Bancroftian filariasis infection, disease, and specific antibody response patterns in a high and a low endemicity community in East Africa. , 2002, The American journal of tropical medicine and hygiene.

[3]  P. E. Simonsen,et al.  Lymphatic filariasis in Lower Shire, southern Malawi. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  M. Itoh,et al.  Prevalence and intensity of Wuchereria bancrofti antigenaemia in Sri Lanka by Og4C3 ELISA using filter paper-absorbed whole blood. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[5]  T. Nutman,et al.  Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. , 2001, The American journal of tropical medicine and hygiene.

[6]  P. Das,et al.  Tolerability and efficacy of single‐dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India , 2000, Tropical medicine & international health : TM & IH.

[7]  P. Sahoo,et al.  Bancroftian filariasis: prevalence of antigenaemia and endemic normals in Orissa, India. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  E. Michael,et al.  Global mapping of lymphatic filariasis. , 1997, Parasitology today.

[9]  I. Bygbjerg,et al.  Bancroftian filariasis: the patterns of filarial-specific immunoglobulin G1 (IgG1), IgG4, and circulating antigens in an endemic community of northeastern Tanzania. , 1996, The American journal of tropical medicine and hygiene.

[10]  A. Hightower,et al.  Age-specific prevalence of antigenemia in a Wuchereria bancrofti-exposed population. , 1994, The American journal of tropical medicine and hygiene.

[11]  S. Chanteau,et al.  Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. , 1994, The Journal of infectious diseases.

[12]  H. Gelderblom Lymphatic filariasis: the disease and its control. Fifth report of the WHO Expert Committee on Filariasis. , 1992, World Health Organization technical report series.